🕵️ Aldeyra Therapeutics, Inc. ($ALDX)
SEC insider & ownership activity, last 12 months · CIK 1341235 · every row links its SEC filing
Over the last 12 months insiders bought $524K with no open-market selling against it. Todd C. Brady bought $418K in discretionary trades (Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $524K (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Todd C. Brady | 1 | $418K | 0 | – | Jun 3, 2026 |
| Douglas Richard | 1 | $98K | 0 | – | Mar 19, 2026 |
| Alfieri Michael | 1 | $7K | 0 | – | Mar 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| AQR Capital Management, LLC | 6.2% | 13G | Aug 12, 2026 | filing ↗ | |
| AQR Capital Management Holdings, LLC | 6.2% | 13G | Aug 12, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 17, 2026 | filing ↗ |
| Other events (8.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 23, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 15, 2025 | filing ↗ |
| Other events (8.01) | Dec 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 15, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Other events (8.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Other events (8.01) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |